REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,400,968 | +7.3% | 50,613 | +3.7% | 0.01% | +12.5% |
| Q2 2023 | $1,305,801 | +43.6% | 48,815 | +16.3% | 0.01% | +33.3% |
| Q1 2023 | $909,157 | +7.0% | 41,974 | +17.7% | 0.01% | 0.0% |
| Q4 2022 | $849,469 | +21.9% | 35,662 | +0.9% | 0.01% | +20.0% |
| Q3 2022 | $697,000 | +21.2% | 35,351 | +19.8% | 0.01% | +25.0% |
| Q2 2022 | $575,000 | -23.5% | 29,500 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $752,000 | -5.3% | 29,489 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $794,000 | -11.2% | 31,565 | -2.9% | 0.00% | -20.0% |
| Q3 2021 | $894,000 | -15.3% | 32,509 | -2.3% | 0.01% | +25.0% |
| Q2 2021 | $1,056,000 | -7.5% | 33,281 | +33.7% | 0.00% | 0.0% |
| Q1 2021 | $1,142,000 | +28.6% | 24,895 | +11.0% | 0.00% | +33.3% |
| Q4 2020 | $888,000 | +10.6% | 22,426 | -2.8% | 0.00% | -25.0% |
| Q3 2020 | $803,000 | +183.7% | 23,069 | +157.4% | 0.00% | +300.0% |
| Q2 2020 | $283,000 | +54.6% | 8,963 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $183,000 | – | 8,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |